Daniel Mahony

Daniel Mahony

Presidente en TRELLUS HEALTH PLC .

Fortuna: 5 353 $ al 30/04/2024

Finance
Health Technology
Commercial Services

Origen de la red de primer grado Daniel Mahony.

EntidadTipo de entidadIndustria
90
Subsidiary Investment Managers 90
21
Non-Profit Organization Miscellaneous Commercial Services 21
Public Company Biotechnology 15
14
Subsidiary Financial Conglomerates 14
11
Subsidiary Miscellaneous Commercial Services 11
Public Company Internet Software/Services 11
9
Holding Company Pharmaceuticals: Major 9
5
Subsidiary Biotechnology 5
1
Holding Company Packaged Software 1

Gráfico Empresas conectadas de segundo grado

Relaciones con varias empresas

Empresas conectadas a Daniel Mahony a través de su red personal

EmpresaSectorPersonas relacionadasPuesto principal
Biotechnology

Frank Shannon

Corporate Officer/Principal

INCYTE CORPORATION Pharmaceuticals: Major

Susanne Antonie Schaffert

Director/Board Member

PFIZER, INC. Pharmaceuticals: Major

Ruth McKernan

Viviane Monges

Corporate Officer/Principal

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Sarah Fromson

Paul Schreier

Corporate Officer/Principal

Chief Executive Officer

Investment Managers

Ruth McKernan

David Edward Pinniger

Private Equity Investor

Private Equity Analyst

NOVO NORDISK A/S Pharmaceuticals: Major

Lars Rebien Sørensen

Thomas Dyrberg

Kasim Kutay

Chief Executive Officer

Corporate Officer/Principal

Director/Board Member

Medical Specialties

Philip Toleikis

Frank Holler

Chief Tech/Sci/R&D Officer

Director/Board Member

Pharmaceuticals: Major

Susanne Antonie Schaffert

Chief Executive Officer

TEARLAB CORPORATION Medical Specialties

Frank Shannon

Corporate Officer/Principal

Miscellaneous Commercial Services

Ruth McKernan

James Brown

Director/Board Member

Chief Tech/Sci/R&D Officer

GALAPAGOS NV Biotechnology

Susanne Antonie Schaffert

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Susanne Antonie Schaffert

Viviane Monges

Investor Relations Contact

Director of Finance/CFO

University of Pennsylvania College/University

Steven J. Winick

David Sable

Undergraduate Degree

Doctorate Degree

Investment Trusts/Mutual Funds

Lars Rebien Sørensen

Thomas Dyrberg

Chairman

Chief Executive Officer

Biotechnology

Frank Shannon

Corporate Officer/Principal

University of Cambridge College/University

Francis Cuss

Daniel Abrams

Abhijeet Lele

Sunil Shah

Michael Anthony Romanos

Piraye Yurttas Beim

Lisa Anson

Doctorate Degree

Graduate Degree

Graduate Degree

Masters Business Admin

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Queen's University College/University

Clare Elizabeth Terlouw

Marla Dubinsky

Undergraduate Degree

Doctorate Degree

Medical Specialties

James Brown

Mike Salter

Corporate Officer/Principal

Corporate Officer/Principal

University of London College/University

Ruth McKernan

Peter R. Luff

Kyriacos Mitrophanous

Doctorate Degree

Graduate Degree

Doctorate Degree

The University of Texas at Austin College/University

Piraye Yurttas Beim

Angie Lee

Undergraduate Degree

Undergraduate Degree

College/University

Abhijeet Lele

Laura Towart Bandak

Masters Business Admin

Graduate Degree

University of British Columbia College/University

Philip Toleikis

Frank Holler

Modestus Obochi

Doctorate Degree

Masters Business Admin

Doctorate Degree

University of Michigan College/University

Philip Toleikis

Jim Trenkle

Graduate Degree

Undergraduate Degree

Copenhagen Business School College/University

Lars Rebien Sørensen

Max Løwe

Undergraduate Degree

Graduate Degree

Pharmaceuticals: Major

Lars Rebien Sørensen

Viviane Monges

Director/Board Member

Director/Board Member

ENDOCYTE, INC. Pharmaceuticals: Major

Susanne Antonie Schaffert

Director/Board Member

Pharmaceuticals: Major

Frank Shannon

Corporate Officer/Principal

Friedrich-Alexander University of Erlangen-Nuremberg College/University

Susanne Antonie Schaffert

Doctorate Degree

University of Copenhagen College/University

Lars Rebien Sørensen

Thomas Dyrberg

Graduate Degree

Doctorate Degree

ESCP Europe Campus Paris College/University

Emmanuelle Coutanceau

Viviane Monges

Graduate Degree

Masters Business Admin

Icahn School of Medicine at Mount Sinai College/University

Erik Lium

Marla Dubinsky

Director/Board Member

Director/Board Member

Information Technology Services

Frank Shannon

Corporate Officer/Principal

Miscellaneous Commercial Services

Ian Tomlinson

Martin Dougherty

Corporate Officer/Principal

Chief Operating Officer

Investment Managers

Emmanuelle Coutanceau

Søren Møller

Private Equity Investor

Director of Investments

i3 Innovus Investment Managers

Frank Shannon

Corporate Officer/Principal

ADVANCED ACCELERATOR APPLICATION SA(ADR) Medical Specialties

Susanne Antonie Schaffert

Chairman

Biotechnology

Ian Tomlinson

Clare Elizabeth Terlouw

Chairman

Director/Board Member

RUBIUS THERAPEUTICS Biotechnology

Francis Cuss

Susanne Antonie Schaffert

Director/Board Member

Director/Board Member

Medical Distributors

Susanne Antonie Schaffert

Director/Board Member

Financial Conglomerates

Lars Rebien Sørensen

Kasim Kutay

Chairman

Chief Executive Officer

RENALYTIX PLC Packaged Software

Salim Hamir

Erik Lium

Corporate Secretary

Director/Board Member

Electronic Components

Susanne Antonie Schaffert

Director/Board Member

VERICI DX PLC Medical/Nursing Services

Salim Hamir

Erik Lium

Corporate Secretary

Director/Board Member

Pharmaceuticals: Major

Susanne Antonie Schaffert

Corporate Officer/Principal

Ripple Therapeutics Corp.

Frank Shannon

General Counsel

Hospital/Nursing Management

Susanne Antonie Schaffert

Director/Board Member

Estadísticas

Internacional

Estados Unidos 19
Reino Unido 12
Dinamarca 8
Canadá 6
Alemania 5

Sectorial

Health Technology 20
Consumer Services 14
Miscellaneous 5
Finance 5
Commercial Services 3

Operativa

Director/Board Member 264
Corporate Officer/Principal 96
Portfolio Manager-Equities 49
Chairman 46
Chief Executive Officer 44
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA